| abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: group of inventions relates to medicine and deals with method for stabilisation of protein of human blood plasma with molecular weight higher than 10 kDa by addition of melicitose into solution, which contains protein of human blood plasma with molecular weight higher than 10 kDa, which represents pharmaceutically or biologically important protein of human blood plasma or recombinantly obtained protein of human blood plasma, selected from the group, consisting of FIX, FVIII or HES-G-CSF. Group of inventions also deals with application of melicitose for stabilisation of protein of human blood plasma with molecular weight higher than 10 kDa, where protein represents factor VII, factor IX or HES-G-CSF. n EFFECT: group of inventions provides stabilisation of solution, containing factor VII, factor IX or HES-G-CSF. n 26 cl, 6 ex, 11 tbl |